J. Popp

DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

S. Leucht, S. Heres, W. Steimer, 2009, The Pharmacogenomics Journal.

High-speed genotyping of CYP1A2*1F mutation with fluorescent hybridization probes using the LightCycler.

W. Steimer, B. Messner, J. Popp, 2003, Pharmacogenomics.

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy.

S. Leucht, Werner Kissling, W. Steimer, 2005, Clinical chemistry.

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers.

S. Leucht, Werner Kissling, W. Steimer, 2004, Clinical chemistry.

Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.

S. Leucht, S. Heres, W. Steimer, 2006, Pharmacogenomics.